Tuesday, August 3, 2010

Fragile X Clinical Trials Show Promise

For 25 years, Brenda Finucane has helped families cope with developmental disabilities in her role as a genetic counselor at Elwyn Training & Research Institute in Middletown.
However, she feels especially close to those living with fragile X syndrome, a group of genetic disorders that can affect individuals in a variety of ways.
"It's the most common inherited form of intellectual disabilities, and it’s in all populations," said Finucane. "It's estimated that one in every 3,600 males and one in 6,000 females are affected by the syndrome."
July 24, Finucane got what she considers possibly the best news of her professional life. Clinical trials of a medication in which six Elwyn clients participated have produced promising results.
"This is huge. This is actually working toward correcting the brain chemistry," the 52-year-old Upper Providence resident said.

No comments:

Post a Comment